Back to Search
Start Over
Multimodal treatment according to the NPC-GPOH trials in adult patients with nasopharyngeal cancer-Analysis based on a single-center experience.
- Source :
-
Cancer reports (Hoboken, N.J.) [Cancer Rep (Hoboken)] 2024 Aug; Vol. 7 (8), pp. e2111. - Publication Year :
- 2024
-
Abstract
- Background and Aim: The German NPC-GPOH trials introduced treatment including neoadjuvant chemotherapy, radiochemotherapy (RCT) and antiviral treatment in patients aged 25 years or younger with nasopharyngeal cancer (NPC). We conducted a retrospective study on outcomes of patients at the age of ≥26 years treated accordingly at our institution.<br />Methods: Consecutive patients who received primary RCT for NPC were included. The Kaplan-Meier method was used to calculate survival probabilities, and the Cox regression analysis was used to test for an influence of the variables on outcomes. Acute and late toxicity were evaluated via CTCAE criteria and LENT/SOMA criteria, respectively.<br />Results: In total, 30 patients were included. Diagnosis was made from 09/1994 to 11/2016. The median 5 year overall survival (OS), disease-free survival (DFS), cancer-specific survival (CSS) and locoregional recurrence-free survival (LRC) were 75%, 56%, 83%, and 85%, respectively. We found a negative impact on outcomes (p < .05) in case of older age (OS), history of smoking (OS), and T4 stage/ UICC stage IV (DFS). WHO histologic type significantly influenced outcomes, with best outcomes for type III and worst outcomes for type I. The rates of acute and late toxicities were acceptable.<br />Conclusion: We found excellent outcomes and good feasibility of the NPC-GPOH trials regimen in adult patients. Additionally, we identified patients with outcomes which need to be improved (smokers, histologic type I tumors) and with particularly excellent outcomes (histologic type III tumors). This stimulates further studies on treatment intensification or de-escalation aiming at reduced side effects with optimal tumor control in NPC.<br /> (© 2024 The Author(s). Cancer Reports published by Wiley Periodicals LLC.)
- Subjects :
- Humans
Male
Female
Adult
Retrospective Studies
Middle Aged
Young Adult
Nasopharyngeal Carcinoma therapy
Nasopharyngeal Carcinoma mortality
Nasopharyngeal Carcinoma pathology
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Neoplasm Staging
Aged
Antiviral Agents therapeutic use
Antiviral Agents administration & dosage
Disease-Free Survival
Combined Modality Therapy methods
Survival Rate
Nasopharyngeal Neoplasms therapy
Nasopharyngeal Neoplasms mortality
Nasopharyngeal Neoplasms pathology
Chemoradiotherapy methods
Neoadjuvant Therapy methods
Subjects
Details
- Language :
- English
- ISSN :
- 2573-8348
- Volume :
- 7
- Issue :
- 8
- Database :
- MEDLINE
- Journal :
- Cancer reports (Hoboken, N.J.)
- Publication Type :
- Academic Journal
- Accession number :
- 39191673
- Full Text :
- https://doi.org/10.1002/cnr2.2111